The Protein Acetyltransferase ARD1: A Novel Cancer Drug Target?

E-ISSN： 1873-5576|8|7|545-553

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.7, 2008-11, pp. : 545-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Arylamine N-Acetyltransferase 1: A Drug-Metabolizing Enzyme and a Drug Target?

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 759-766

Bentham Science Publishers

Access to resources Recommend Favorite

Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer

Current Molecular Pharmacology, Vol. 4, Iss. 3, 2011-11 ,pp. : 167-175

Bentham Science Publishers

Access to resources Recommend Favorite

Capsid (CA) Protein as a Novel Drug Target: Recent Progress in the Research of HIV-1 CA Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 4, 2009-04 ,pp. : 510-518

Bentham Science Publishers

Access to resources Recommend Favorite

The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?

By McCluskey A. Ackland1 S.P. Gardiner E. Walkom C.C. Sakoff1 J.A.

Anti-Cancer Drug Design, Vol. 16, Iss. 6, 2001-12 ,pp. : 291-303

Cognizant Communication Corporation

Access to resources Recommend Favorite

WT1 as a Novel Target Antigen for Cancer Immunotherapy

Current Cancer Drug Targets, Vol. 2, Iss. 1, 2002-03 ,pp. : 45-54

Bentham Science Publishers

Access to resources Recommend Favorite